Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
This unique therapeutic topical agent is capable of healing wounds/scars/burns and has many potential uses in the dermatological, dental and hospital/surgery market. More
Guided Bone Regeneration Membrane in Dental Surgery More
The omega-3 fatty acids are extracted from New Zealand green lipped mussels and developed into oils for use in anti-inflammatory compounds by our UK based clients. More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Prevents oral trauma to surgical or long term ventilated patients due to insertion of endotracheal tube; additionally this novel device is beneficial in endoscope labs for both bronchoscope and transesophageal echocardiogram (TEE) procedures. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
This TACE inhibitory protein could be used as a new therapeutic agent against chronic inflammatory diseases that are mediated by TNF-alpha. More
Scientists have developed novel biomaterials comprising of modified hydroxyapatite (HA) which can be used to improve bone, dental and oral health products as well as implant anchoring into the body. More
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2008 - 85 pages - $1,995
Jan 2011 - 15 pages - $99
Nov 2010 - 15 pages - $99
Sep 2010 - 13 pages - $99
Jul 2010 - 13 pages - $99
Aug 2010 - 25 pages - $99
Sep 2010 - 13 pages - $99
Feb 2011 - 22 pages - $99
Apr 2010 - 23 pages - $99
Oct 2010 - 25 pages - $99
Your selection
- Therapeutic target
- Oral Health del
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Aphthous ulcers
- Dental disorder (other)
- Gingivitis
- Gum disease
- Herpes simplex virus type 1 (oral)
- Mouth disorder (other)
- Mucositis oral
- Mucositis, Radiation-induced
- Periodontal disease
- Tooth decay
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us